PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.42%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-74.75%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
0.94%
Gross profit growth below 50% of CRWD's 5.45%. Michael Burry would check for structural issues.
2.39%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
9.88%
R&D growth above 1.5x CRWD's 3.75%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.09%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
6.70%
Total costs growth above 1.5x CRWD's 4.38%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
59.44%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
-3.89%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
13.85%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
-9.63%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-8.33%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-578.72%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-26.08%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-25.01%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-5.27%
Both companies reducing tax expense. Martin Whitman would check patterns.
-37.28%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-36.37%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-36.36%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-35.00%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
1.02%
Share count reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.
1.33%
Diluted share reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.